Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-691-5 | CAS number: 590-86-3
Carcinogenicity
Administrative data
Description of key information
Key value for chemical safety assessment
Justification for classification or non-classification
Classification concerning carcinogenicity is not warranted.
Additional information
The carcinogenic potential of isobutyraldehyde was examined in two rodents studies.
A 2-year inhalation study was reported (NTP, 1999). In this study (done with NTP standards), male and female rats were given vapour concentrations of 500, 1000 and 2000 ppm (= 1.5, 3 and 6 mg/l). No increase in neoplasm incidences that could be attributed to exposure to isobutyraldehyde was observed in male or female rats. Non-neoplastic lesions related to isobutyraldehyde exposure were limited to the nose and consisted of squamous metaplasia of the respiratory epithelium, degeneration of the olfactory epithelium, and suppurative inflammation. Incidences of minimal to mild squamous metaplasia in 1000 and 2000 ppm males and females and in 500 ppm females were significantly greater than those in the chamber controls. Minimal to mild degeneration of the olfactory epithelium occurred in the 2000 ppm males and females. Incidences of suppurative inflammation (rhinitis) in both sexes exposed to 2000 ppm were increased compared to controls. The LOAEC was found to be 500 ppm.
Another 2-year inhalation study (NTP, 1999) using male and female mice showed also a negative result. Mice were given vapour concentrations of 500, 1000 and 2000 ppm (= 1.5, 3 and 6 mg/l). No neoplasms that could be attributed to isobutyraldehyde exposure were observed in either males or females. Non-neoplastic lesions related to isobutyraldehyde exposure were limited to the nose. The incidences of olfactory epithelial degeneration in 1000 and 2000 ppm males and females were significantly greater than in the chamber controls. The NOAEC was found to be 500 ppm. This study was done with NTP-standards.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
